English | 简体中文 | 繁體中文 | 한국어 | 日本語
ACN Newswire provides full service, real time press release distribution for companies and organizations wishing to disclose and disseminate information to media, business, and the financial markets worldwide.
ACN Newswire distributes press releases in English, Simplified Chinese, Traditional Chinese, Korean and Japanese.
 Latest Press Releases
卓悅集團旗下卓悅奧特萊斯Beauty Outlet開幕  
Jul 15, 2024 22:58 HKT/SGT
Malaysian Aviation Commission Handpicks Indonesia's TransNusa Airlines as One of the Two Foreign Airlines to Operate from its distinguished Subang Airport  
Jul 15, 2024 21:00 HKT/SGT
卓悦集团旗下卓悦奥特莱斯Beauty Outlet开幕  
Jul 15, 2024 20:56 HKT/SGT
Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025  
Jul 15, 2024 19:00 HKT/SGT
Telin and BW Digital to enhance DC-to-DC connectivity with new Indonesia - Singapore cable  
Jul 15, 2024 17:50 HKT/SGT
Legend Capital's Portfolio Company Singfilm Solar Achieves Breakthrough in Perovskite Solar Cell Efficiency  
Jul 15, 2024 17:10 HKT/SGT
NEC transfers a portion of its shares in NEC Capital Solutions, an equity method affiliate  
Jul 15, 2024 16:58 JST
The Malaysian Aviation Commission Handpicks TransNusa as One of Two Foreign Airlines to Launch Flights from Subang Airport  
Jul 15, 2024 15:00: JST
DENSO Hosts Software Strategy Briefing, Shares Company Direction  
Jul 15, 2024 15:05 JST
Komisi Penerbangan Malaysia Memilih TransNusa Sebagai Salah Satu Dari Dua Maskapai Asing Untuk Meluncurkan Penerbangan Dari Bandara Subang  
Jul 15, 2024 14:00 HKT/SGT
The Malaysian Aviation Commission Handpicks TransNusa as One of Two Foreign Airlines to Launch Flights from Subang Airport  
Jul 15, 2024 14:00 HKT/SGT
醫療器械是否回暖 貝康醫療(2170.HK)上半年銷售業績逆勢爆發  
Jul 15, 2024 08:51 HKT/SGT
foundit Survey: 52% of Singaporean organisations show responsiveness to diversity issues, highlighting key growth opportunities   
Jul 15, 2024 08:00 HKT/SGT
医疗器械是否回暖 贝康医疗(2170.HK)上半年销售业绩逆势爆发  
Jul 15, 2024 07:42 HKT/SGT
Brawijaya Academic makes Mulch from Banana Waste and Water Hyacinth   
Jul 15, 2024 02:00 HKT/SGT
中信國際電訊CPC“智賦雲網安”創新能力再獲業界肯定  
Jul 13, 2024 01:00 HKT/SGT
中信国际电讯CPC“智赋云网安”创新能力再获业界肯定  
Jul 13, 2024 01:00 HKT/SGT
CITIC Telecom CPC's 'AI+ Cloud Network Security' Innovation Continues to Attain Recognition for Unmatched Capabilities  
Jul 13, 2024 00:05 HKT/SGT
MooFest 2024 by Moomoo Singapore and AlphaInvest Receives Massive Turnout  
Jul 12, 2024 19:30 HKT/SGT
TOYOTA GAZOO Racing faces a new challenge with full strength  
Jul 12, 2024 19:15 JST
MHI Selected for Inclusion in Two ESG Investment Indices: FTSE Blossom Japan Index and FTSE Blossom Japan Sector Relative Index  
Jul 12, 2024 16:13 JST
TGR Announces Upgraded GR86 and Limited Special-edition Model  
Jul 12, 2024 14:48 JST
Asia-Pacific youth and Habitat for Humanity join hands to implement solutions for decent housing  
Jul 12, 2024 13:06 HKT/SGT
三菱重工、ESG指数「FTSE Blossom Japan Index」および「FTSE Blossom Japan Sector Relative Index」の構成銘柄に選定  
Jul 12, 2024 12:00: JST
"LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Israel  
Jul 12, 2024 12:56 JST
エーザイとバイオジェン、「レケンビ」(レカネマブ)がイスラエルにおいてアルツハイマー病治療剤として承認を取得  
Jul 12, 2024 09:00: JST
KSL Capital Partners และ Soneva Resorts: เรื่องราวที่ควรระวังเกี่ยวกับการตรวจสอบสถานะ  
Jul 12, 2024 09:00 HKT/SGT
KSL Capital Partners & Soneva Resorts: A Cautionary Tale of Due Diligence  
Jul 12, 2024 08:34 HKT/SGT
Q2 Metals Updates Private Placement  
Jul 12, 2024 08:00 HKT/SGT
Fonos Sees Monthly Active Users Increase to 6X with CleverTap's Personalized Engagement  
Jul 11, 2024 15:00 HKT/SGT
Singapore's 'Samsui Woman' Mural Controversy: Asia's Prestigious 28 Fevrier Gallery Signs American Artist Sean Dunston  
Jul 11, 2024 12:00 HKT/SGT
上市一年碩果紛呈 科倫博泰備戰商業化劍指Biopharma 估值躍升即將開啟  
Jul 11, 2024 11:39 HKT/SGT
上市一年硕果纷呈 科伦博泰备战商业化剑指Biopharma 估值跃升即将开启  
Jul 11, 2024 11:11 HKT/SGT
Greta Minerals Secures Lithium and REE Assets in Western Australia  
Jul 11, 2024 10:00 HKT/SGT
エーザイとバイオジェン、「LEQEMBI」(レカネマブ)が香港においてアルツハイマー病治療剤として承認を取得  
Jul 11, 2024 10:00: JST
LEQEMBI (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Hong Kong  
Jul 11, 2024 10:00 JST
DRIL-QUIP (NYSE: DRQ): Kaplan Fox & Kilsheimer LLP Investigates Dril-Quip Following Disclosure of $67 Million of Misclassified Inventory Write-Downs  
Jul 11, 2024 08:00 HKT/SGT
AI-Blockchain Platform ChainGPT Secures Launchpad with Blockpass KYC  
Jul 10, 2024 23:50 HKT/SGT
CEO Periodic Update for 2024 and Review on the Market of the Growing FemTech industry  
Jul 10, 2024 21:06 HKT/SGT
瑞昌國際控股成功登陸港股市場 首日上漲14.29%  
Jul 10, 2024 20:32 HKT/SGT
瑞昌国际控股成功登陆港股市场 首日上涨14.29%  
Jul 10, 2024 19:46 HKT/SGT
Japan Aircraft Industrial Enhancement Co. Ltd. to Start Operations  
Jul 10, 2024 18:04 JST
Q2 Metals Announces $7.5 Million Private Placement  
Jul 10, 2024 15:05 HKT/SGT
Eton Solutions Launches AtlasFive for Family Office Wealth Management in India; Onboards Catamaran as its Launch Customer  
Jul 10, 2024 14:20 HKT/SGT
三菱重工、「日本航空機産業振興株式会社」の事業開始を発表  
Jul 10, 2024 14:00: JST
アリックスパートナーズ、「2024年版グローバル自動車業界見通し」を発表  
Jul 10, 2024 12:30: JST
ソフトバンクとNEC、企業や自治体のDX推進に向けて生体認証領域を中心とした戦略的提携に合意  
Jul 10, 2024 09:00: JST
DRIL-QUIP (NYSE: DRQ): Investigation of Dril-Quip for Potential Securities Law Violations  
Jul 10, 2024 08:00 HKT/SGT
More News >>
 ACN Search:
 
Vice President Ma'ruf Amin waves to residents in the Malawei Fishing Village, Sorong Manoi District, Sorong City, West Papua, on 6 June 2024. The Indonesian government targeted building 350 houses for indigenous Papuan fishers in 2014, but only 40 houses have been completed due to technical constraints, including environmental impact assessments (AMDAL permits). The remaining houses will be completed in 2024/25. (ANTARA FOTO/Olha Mulalinda/Spt.)
 
Daily Newsletter
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575